The RAPiDgen® SARS-CoV-2 Ag test is a rapid lateral flow-based assay for qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in human nasal swab samples of individuals suspected of COVID-19.
The RAPiDgen® SARS-CoV-2 Ag Test is a rapid test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in human nasal samples.
The test is used to detect antigens of the SARS-CoV-2 virus in individuals suspected of having COVID-19, with a sterile nasal swab. It is designed as a self-test for patients and by professional medical personnel. (For In-Vitro Diagnostic Use)
Perform the RAPiDgen® SARS-CoV-2 Ag test when there is a suspected for COVID-19 exposure or respiratory infection related symptoms such as, fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
- The test is intended for all ages
- The test should be performed by a person over the age of 16 or under adult supervision for self-testing or home-use testing
ADALTIS is deeply committed to supporting the global response to the COVID-19 pandemic.
Adaltis supply diagnostics solutions for SARS CoV-2 Virus testing all around the world and cover all diagnostic methods as Molecular Diagnostics RT-PCR Tests, ELISA Tests IgA, IgM, IgG & Total Antibody, as well the Ag Test.
Sign up to hear from us.
RAPiDgen - Rapid Tests Line ADALTIS
Via Luigi Einaudi 7 , Guidonia Montecelio , Rome , 00012 Italy